Developer of novel human immunomodulatory proteins and drugs designed to treat cancer and autoimmune diseases. The company's drugs use proteins that have direct anti-tumor effects that remodel the tumor microenvironment and develop antibodies to block the activation of specific HLA molecules associated with autoimmune diseases, helping healthcare providers with biologic therapeutics.